|
|
|
Insider
Information: |
Garcia Peter S |
Relationship: |
Director |
City: |
Sunnyvale |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
412,377 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$626,961 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
412,377 |
|
|
Total
Value |
$626,961 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Adhera Therapeutics, Inc |
ATRX |
Chief Financial Officer |
2011-03-31 |
5,000 |
2011-03-31 |
0 |
Premium* |
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Chief Financial Officer |
2011-11-29 |
2,000 |
2011-11-29 |
0 |
Premium* |
|
PDL Biopharma Inc |
PDLI |
Vice President, CFO |
2018-12-27 |
225,029 |
2013-05-23 |
0 |
Premium* |
|
Alx Oncology Holdings Inc |
ALXO |
|
2024-02-14 |
110,348 |
2020-07-21 |
0 |
Premium* |
|
Durect Corp |
DRRX |
Director |
2021-12-13 |
70,000 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALXO |
Alx Oncology Holdings Inc |
CHIEF FINANCIAL OFFICER |
|
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
110,348 |
0 |
- |
|
ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
|
2023-12-29 |
4 |
S |
$15.04 |
$28,471 |
D/D |
(1,893) |
85,348 |
0 |
- |
|
ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
|
2023-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
32,000 |
86,738 |
0 |
- |
|
ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
|
2023-06-30 |
4 |
S |
$7.34 |
$6,511 |
D/D |
(887) |
54,738 |
0 |
- |
|
ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
|
2022-12-29 |
4 |
S |
$11.07 |
$9,886 |
D/D |
(893) |
53,723 |
0 |
- |
|
ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
|
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
29,000 |
55,178 |
0 |
- |
|
ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
|
2022-02-07 |
4 |
OE |
$4.08 |
$67,305 |
D/D |
15,000 |
24,483 |
0 |
- |
|
DRRX |
Durect Corp |
Director |
|
2021-12-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
70,000 |
|
% |
|
ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
|
2021-10-18 |
4 |
OE |
$4.08 |
$29,494 |
D/D |
7,229 |
16,560 |
0 |
- |
|
ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
|
2021-10-18 |
4 |
AS |
$54.33 |
$400,793 |
D/D |
(7,229) |
9,331 |
0 |
- |
|
ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
|
2021-09-17 |
4 |
AS |
$77.84 |
$895,811 |
D/D |
(11,345) |
9,331 |
0 |
- |
|
ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
|
2021-09-17 |
4 |
OE |
$4.08 |
$46,288 |
D/D |
11,345 |
20,676 |
0 |
- |
|
ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
|
2021-09-16 |
4 |
AS |
$80.43 |
$114,695 |
D/D |
(1,426) |
9,331 |
0 |
- |
|
ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
|
2021-09-16 |
4 |
OE |
$4.08 |
$5,818 |
D/D |
1,426 |
10,757 |
0 |
- |
|
ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
|
2021-08-23 |
4 |
OE |
$4.08 |
$244,800 |
D/D |
60,000 |
69,331 |
0 |
- |
|
ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
|
2021-08-23 |
4 |
AS |
$70.86 |
$4,448,762 |
D/D |
(60,000) |
9,331 |
0 |
- |
|
ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
|
2021-08-17 |
4 |
AS |
$65.24 |
$662,299 |
D/D |
(10,000) |
9,331 |
0 |
- |
|
ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
|
2021-08-17 |
4 |
OE |
$4.08 |
$40,800 |
D/D |
10,000 |
19,331 |
0 |
- |
|
ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
|
2021-01-28 |
4 |
OE |
$4.08 |
$25,002 |
D/D |
6,128 |
9,128 |
0 |
- |
|
ALXO |
Alx Oncology Holdings Inc |
Chief Financial Officer |
|
2020-07-21 |
4 |
B |
$19.00 |
$57,000 |
D/D |
3,000 |
3,000 |
2.74 |
- |
|
PDLI |
PDL Biopharma Inc |
Vice President, CFO |
|
2018-12-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(226,442) |
225,029 |
0 |
- |
|
PDLI |
PDL Biopharma Inc |
Vice President, CFO |
|
2018-12-27 |
4 |
D |
$3.02 |
$10,730 |
D/D |
(3,553) |
451,471 |
0 |
- |
|
PDLI |
PDL Biopharma Inc |
Vice President, CFO |
|
2017-12-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(17,818) |
455,024 |
0 |
- |
|
PDLI |
PDL Biopharma Inc |
Vice President, CFO |
|
2017-03-24 |
4 |
B |
$1.97 |
$49,401 |
D/D |
25,000 |
472,842 |
2.74 |
- |
|
PDLI |
PDL Biopharma Inc |
Vice President, CFO |
|
2017-03-04 |
4 |
A |
$2.04 |
$433,845 |
D/D |
212,669 |
447,842 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|